Le Lézard
Classified in: Health
Subject: SVY

Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2017


LONDON, Nov. 16, 2017 /PRNewswire/ --

Download the full report: https://www.reportbuyer.com/product/3895267

The report provides insights into Overactive Bladder epidemiology, Overactive Bladder diagnosed patients, and Overactive Bladder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Overactive Bladder derived from epidemiological analysis, percentage of patients diagnosed with Overactive Bladder, and percentage of patients treated with a therapy.

The study helps executives estimate Overactive Bladder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Overactive Bladder prevalence, Overactive Bladder diagnosis rate, and Overactive Bladder treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Overactive Bladder Patient Flow
- Overactive Bladder Prevalence
- Overactive Bladder Diagnosed Patients
- Overactive Bladder Treated Patients

Download the full report: https://www.reportbuyer.com/product/3895267

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

at 08:45
Cannabix Technologies Inc. (the "Company or Cannabix") developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC ("Friedel Clinic") a private monitoring agency, based in...

at 08:43
The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, announces that Purina has donated $111,910 in support of CHF-funded canine health research thanks to its Purina Parent...

at 08:41
eRSP, a trailblazer in innovative home health solutions, proudly reveals a new brand alongside a refreshed website. This step showcases eRSP's commitment to transformation, innovation and lays the groundwork for what the home health industry can...

at 08:35
Vistagen , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an...

at 08:34
Canopy Life Sciences ("Canopy"), a leading provider of clinical to commercial solutions to the life sciences industry, is delighted to announce the appointment of Susanne Clark as President. With over 25 years of experience in the life sciences...

at 08:34
Innovative Medical Products, Inc. (IMP) and Curexo Inc. are pleased to announce a global strategic distribution partnership combining Curexo's artificial joint surgical robot, CUVIS-joint, with IMP's industry-leading De Mayo D2® Knee Positioner....



News published on and distributed by: